The strain Pseudomonas putida DOT-T1E was tested for its ability to tolerate second phases of different alkanols for their use as solvents in two-liquid-phase biotransformations. Although 1-decanol showed an about 10-fold higher toxicity to the cells than 1-octanol, the cells were able to adapt completely to 1-decanol only and could not be adapted in order to grow stably in the presence of a second phase of 1-octanol. The main explanation for this observation can be seen in the higher water and membrane solubility of 1-octanol. The hydrophobicity (log P) of a substance correlates with a certain partitioning of that compound into the membrane. Combining the log P value with the water solubility, the maximum membrane concentration of a compound can be calculated. With this simple calculation, it is possible to predict the property of an organic chemical for its potential applicability as a solvent for two-liquid-phase biotransformations with solventtolerant P. putida strains. Only compounds that show a maximum membrane concentration of less than 400 mM, such as 1-decanol, seem to be tolerated by these bacterial strains when applied in supersaturating concentrations to the medium. Taking into consideration that a solvent for a two-liquid-phase system should possess partitioning properties for potential substrates and products of a fine chemical synthesis, it can be seen that 1-decanol is a suitable solvent for such biotransformation processes. This was also demonstrated in shake cultures, where increasing amounts of a second phase of 1-decanol led to bacteria tolerating higher concentrations of the model substrate 3-nitrotoluene. Transferring this example to a 5-liter-scale bioreactor with 10% (vol/vol) 1-decanol, the amount of 3-nitrotoluene tolerated by the cells is up to 200-fold higher than in pure aqueous medium. The system demonstrates the usefulness of two-phase biotransformations utilizing solventtolerant bacteria.Biocatalysis using whole cells promised to play an important role in the industrial synthesis of fine chemicals, pharmaceuticals, and precursors for chemical syntheses. However, the number of successful processes using whole-cell biotransformations is very small so far because several factors limit the number of applications (29,30). One important limitation of a successful application of whole-cell biotechnological processes toward classical chemical synthesis is that many reactions of interest involve substrates or products that are extremely toxic for the bacteria (35). This problem can be solved by the application of an organic solvent phase that functions as a source and a sink for toxic organic substrates and products, respectively (36). For biotransformations with whole cells, the major advantage of an addition of a second organic phase lies within its ability to act as a sink for the substrates as well as in the continuous removal of products (19,21,36). In both cases, the presence of a solvent phase keeps the concentrations of substrates and toxins at a level that does not lead to toxic e...